Shiloni Eitan

without-picture

Alma Mater

Hadassah – Hebrew University Medical School, Jerusalem Israel

Main Research Area

Prof. Shiloni”s clinical interests are focused on surgical oncology: malignant melanoma, breast cancer, colorectal cancer as well as surgical endocrinology (thyroid and parathyroid). He has both researched and applied tumor immunotherapy using IL-2 and adoptive transfer of Tumor Infiltrating Lymphocytes (TIL). In recent years he is mainly focused on investigating (in colaboration with Dr. Igor Sukhotnik from Bnai Tzion Hospital) short bowel syndrome and ischemia-reperfusion injury in a rat model.

Research projects

1. Tumor Immunotherapy and cancer vaccines
2. Short Bowel Syndrome
3. Ischemia-Reperfusion injury

Journal articles

Click here for a list of available publications in PubMed.